Evaluate the Clinical Efficacy of Insty in the Treatment of Pyrexia

Abstract

To evaluate safety and efficacy of Anti-pyretic granules in patients with upper respiratory tract infection (URTI) with cough, cold, and flu symptoms along with pyrexia.

Introduction: Herbs had been used by all cultures throughout history. Many drugs commonly used today are of herbal origin. The modern day scientific techniques have proven benefits of herbal drugs. The present study was designed to scrutinize the antipyretic activity of Herbion Anti-pyretic granules in patients with upper respiratory tract infection (URTI) including cough, cold, and flu along with mild to moderate fever. Method: Randomized open clinical study in 50 patients including Children, Adult Male and Female patients with pyrexia associated with cough, cold or flu. Herbion Anti-pyretic granules were given at a dose of 2-3 sachets/day to 50 patients and response of drug is recorded on the scheduled follow-up after 2days and 5days. Results: The overall results shows that out of 50 patients, 39 patients were recovered on day1, 7 patients were recovered on day2 and 4 patients were recovered on day3 at a dose of 2-3 sachets/day.

Conclusion: It was concluded that, the trial drug (Herbion Anti-pyretic granules) were safe, and effective in the treatment of low grade (<102°F) pyrexia associated with upper respiratory tract infection including cough, cold, and flu.